Cargando…
Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
Pancreatic cancer (PC) is one of the most lethal cancers with an almost 10% 5-year survival rate. Because PC is implicated in high heterogeneity, desmoplastic tumor-microenvironment, and inefficient drug-penetration, the chemotherapeutic strategy currently recommended for the treatment of PC has lim...
Autores principales: | Dai, Hong, Abdullah, Razack, Wu, Xiaoqiu, Li, Fangfei, Ma, Yuan, Lu, Aiping, Zhang, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149368/ https://www.ncbi.nlm.nih.gov/pubmed/35652096 http://dx.doi.org/10.3389/fcell.2022.855474 |
Ejemplares similares
-
Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future
por: Zhang, Yihao, et al.
Publicado: (2022) -
RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
por: Wu, Xiaoqiu, et al.
Publicado: (2020) -
Editorial: Aptamer-based structural biology, computational modelling, translational research and drug discovery, Volume II
por: Ma, Yuan, et al.
Publicado: (2023) -
Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research
por: Sun, Meiheng, et al.
Publicado: (2020) -
Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
por: Xie, Bingteng, et al.
Publicado: (2022)